why choose us

First received: October 11, 2023

Clinical Trial: A First-in-Human Study Evaluating AGA2115 in Adult Healthy Volunteers and Adults and Adolescents With OI

Study Status: Completed

Recruit Status: RECRUITING

Condition: Osteogenesis Imperfecta

Study Type: INTERVENTIONAL


Official Title: A Phase 1 Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AGA2115 in Adult Health

Brief Summary: To understand if AGA2115 is safe and well tolerated in both healthy adults and adults/adolescents with Osteogenesis Imperfecta when given as a single dose or multiple doses.

Read more